These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26192106)

  • 1. Alcohol use in bipolar disorder: A neurobiological model to help predict susceptibility, select treatments and attenuate cortical insult.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    Neurosci Biobehav Rev; 2015 Sep; 56():193-206. PubMed ID: 26192106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study.
    Chitty KM; Lagopoulos J; Kaur M; Hickie IB; Hermens DF
    Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risky alcohol use predicts temporal mismatch negativity impairments in young people with bipolar disorder.
    Chitty KM; Kaur M; Lagopoulos J; Hickie IB; Hermens DF
    Biol Psychol; 2014 May; 99():60-8. PubMed ID: 24594113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal glutamatergic/NMDA receptor functioning in bipolar disorder: A study combining mismatch negativity and proton magnetic resonance spectroscopy.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    Psychiatry Res; 2015 Aug; 233(2):88-94. PubMed ID: 26070970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the role of glutathione in mismatch negativity: An insight into NMDA receptor disturbances in bipolar disorder.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    Clin Neurophysiol; 2015 Jun; 126(6):1178-1184. PubMed ID: 25454340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder.
    Chitty KM; Lagopoulos J; Lee RS; Hickie IB; Hermens DF
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1348-63. PubMed ID: 23968965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal proton magnetic resonance spectroscopy study investigating oxidative stress as a result of alcohol and tobacco use in youth with bipolar disorder.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    J Affect Disord; 2015 Apr; 175():481-7. PubMed ID: 25679204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of alcohol and tobacco use on in vivo glutathione in youth with bipolar disorder: an exploratory study.
    Chitty KM; Lagopoulos J; Hickie IB; Hermens DF
    J Psychiatr Res; 2014 Aug; 55():59-67. PubMed ID: 24755258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
    Woo TU; Walsh JP; Benes FM
    Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder.
    Serra G; Koukopoulos A; De Chiara L; Koukopoulos AE; Tondo L; Girardi P; Baldessarini RJ; Serra G
    J Clin Psychiatry; 2015 Jan; 76(1):e91-7. PubMed ID: 25650685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticolimbic connectivity as a possible biomarker for bipolar disorder.
    Vai B; Bollettini I; Benedetti F
    Expert Rev Neurother; 2014 Jun; 14(6):631-50. PubMed ID: 24852228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.
    Stork C; Renshaw PF
    Mol Psychiatry; 2005 Oct; 10(10):900-19. PubMed ID: 16027739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Schizophrenia and/or bipolar disorder: neurobiological endophenotypes].
    Adida M; Azorin JM; Fakra E; Belzeaux R; Kaladjian A; Pomietto P; Corréard N
    Encephale; 2012 Dec; 38 Suppl 3():S98-102. PubMed ID: 23279996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis.
    Ng WX; Lau IY; Graham S; Sim K
    Neurosci Biobehav Rev; 2009 Mar; 33(3):336-54. PubMed ID: 18955079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.
    León-Caballero J; Pacchiarotti I; Murru A; Valentí M; Colom F; Benach B; Pérez V; Dalmau J; Vieta E
    Neurosci Biobehav Rev; 2015 Aug; 55():403-12. PubMed ID: 26014349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P300 component in euthymic patients with bipolar disorder type I, bipolar disorder type II and healthy controls: a preliminary event-related potential study.
    Bersani FS; Minichino A; Fattapposta F; Mannarelli D; Pauletti C; Imperatori C; Spagnoli F; Biondi M; Delle Chiaie R
    Neuroreport; 2015 Mar; 26(4):206-10. PubMed ID: 25674905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological agents under research for the maintenance treatment in bipolar disorder.
    Dimitrakopoulos S; Konstantakopoulos G
    Psychiatriki; 2015; 26(3):169-80. PubMed ID: 26480221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder.
    Dodd S; Fernandes BS; Dean OM
    Curr Neuropharmacol; 2015; 13(5):656-62. PubMed ID: 26467413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.